Product Details for NDA 020381
NIASPAN (NIACIN)
375MG
Marketing Status: Discontinued
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
375MG;500MG;750MG
Marketing Status: Discontinued
375MG
Marketing Status: Discontinued
Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 375MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 001
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
NIASPAN (NIACIN)
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 375MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 001
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 002
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
NIASPAN (NIACIN)
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 002
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 003
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
NIASPAN (NIACIN)
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 003
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 004
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
NIASPAN TITRATION STARTER PACK (NIACIN)
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 004
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
375MG;500MG;750MG
Marketing Status: Discontinued
Active Ingredient: NIACIN
Proprietary Name: NIASPAN TITRATION STARTER PACK
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 375MG;500MG;750MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 005
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: NIASPAN TITRATION STARTER PACK
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 375MG;500MG;750MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020381
Product Number: 005
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status: Discontinued
Patent and Exclusivity Information